Table 2 Demographic Characteristics by Primary Condition among Completers
From: Clinical trials from the patient perspective: survey in an online patient community
N | Age (Mean ± SD) | Sex (Female) | Race (White) | Trial experience | |
|---|---|---|---|---|---|
ALS | 160 | 58 ± 10 | 65 (41%) | 152 (95%) | 57 (36%) |
T2DM | 158 | 58 ± 9 | 79 (50%) | 138 (87%) | 20 (13%) |
Epilepsy | 131 | 47 ± 12 | 83 (63%) | 115 (88%) | 25 (19%) |
Fibromyalgia | 241 | 52 ± 10 | 220 (91%) | 228 (95%) | 26 (11%) |
MS | 343 | 51 ± 9 | 246 (72%) | 300 (87%) | 67 (20%) |
MDD | 91 | 44 ± 12 | 58 (64%) | 83 (91%) | 10 (11%) |
PD | 319 | 63 ± 8 | 171 (54%) | 306 (96%) | 116 (36%) |
RA | 125 | 54 ± 10 | 105 (84%) | 107 (86%) | 20 (16%) |
SLE | 53 | 49 ± 12 | 51 (96%) | 44 (83%) | 5 (9%) |
All Completers | 1,621 | 55 ± 11 | 1078 (67%) | 1473 (91%) | 346 (21%) |